Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging
Diagnostics · 07.11.2024 · 14 (22) · 2487
DOI: 10.3390/diagnostics14222487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 07.11.2024. Verfasst von Yu Ri Shin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reyon Pharmaceutical (South Korea), Reyon Pharmaceutical, Co., Ltd. (Seoul, Republic of Korea).
Abstract (Originalsprache)
Objectives
This study aimed to analyze the usage patterns and hypersensitivity reaction (HSR) profiles of six nonionic iodinated contrast media (ICMs) used in computed tomography (CT) to enhance patient safety and inform evidence-based contrast agent selection.
Methods
We retrospectively reviewed 248,209 CT scans obtained between January 2020 and December 2022. Six ICMs (iomeprol, iohexol, ioversol, iopromide, iodixanol, and iobitridol) were compared on the basis of their usage rates, HSR incidence, and severity. This study also evaluated the impact of premedication protocol reinforcement and assessed the quarterly HSR rates.
Results
Among the 248,209 CT scans, 1603 (0.65%) were associated with HSRs. Most HSRs were mild (86.2%), with moderate (10.9%) and severe (2.9%) reactions being less common. Four ICMs were used as first-line agents and two ICMs were used as second-line agents. The second-line agents, iobitridol and iodixanol, exhibited 7–8 times higher HSR rates compared to the first-line agents. A modified premedication protocol implemented in mid-2022 significantly reduced the incidence of moderate HSRs (p = 0.0075). The quarterly analysis indicated a trend in higher HSR rates in the first quarter and a statistically significant increase in severe HSRs in the third quarter (p = 0.033).
Conclusions
These findings highlight the importance of tailored premedication protocols and a 7–8 times higher rate of HSR with second-line agents in contrast-enhanced imaging. Future research should focus on elucidating the mechanisms underlying these variations to further refine contrast agent selection and management strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea.
- Department of Internal Medicine, Division of Allergy, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Emergency Medicine, Seoul St. Mary Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Yu Ri Shin, Seo Yeon Youn, Hokun Kim, Hyo Joon Kim, Soon Nam Oh
Förderung
- Reyon Pharmaceutical (South Korea)
- Reyon Pharmaceutical, Co., Ltd. (Seoul, Republic of Korea)
Zitieren
APA
Shin, Y. R., Youn, S. Y., Kim, H., Chun, H. J., Lee, H. Y., Kim, H. J., & Oh, S. N. (2024). Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging. Diagnostics, 14(22), 2487. https://doi.org/10.3390/diagnostics14222487
Vancouver
Shin YR, Youn SY, Kim H, Chun HJ, Lee HY, Kim HJ, et al. Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging. Diagnostics. 2024;14(22):2487. doi:10.3390/diagnostics14222487
BibTeX
@article{Shin2024,
author = {Shin, Yu Ri and Youn, Seo Yeon and Kim, Hokun and Chun, Ho Jong and Lee, Hwa Young and Kim, Hyo Joon and Oh, Soon Nam},
title = {Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {22},
pages = {2487},
doi = {10.3390/diagnostics14222487}
}
EUVIMED